| 000 | 00000nam 2200000za 4500 |
| 001 | 9.858915 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107160124 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 180711s2018 onc o f000 0 eng d |
|---|
| 020 | |a9780660271316 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH13-9/17-2018E-PDF |
|---|
| 245 | 00|aGuidance document |h[electronic resource] : |buse of a foreign‐sourced reference product as a Canadian reference product. |
|---|
| 246 | 30|aUse of a foreign‐sourced reference product as a Canadian reference product |
|---|
| 246 | 17|aUse of a foreign‐sources reference product as a CRP |
|---|
| 260 | |aOttawa : |bHealth Canada, |c2018. |
|---|
| 300 | |a13 p. |
|---|
| 500 | |aIssued also in French under title: Ligne directrice : utilisation d'un produit de référence étranger comme produit de référence canadien. |
|---|
| 500 | |aCover title. |
|---|
| 500 | |a"Date adopted: 2017/11/24. Effective date: 2017/11/24. Administrative changes date: 2018/07/12." |
|---|
| 500 | |a"Publication date: July 2018." |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 693 | 4|aDrug approval |
|---|
| 710 | 1 |aCanada. |bHealth Canada. |
|---|
| 775 | 08|tLigne directrice |w(CaOODSP)9.858918 |
|---|
| 856 | 40|qPDF|s371 KB|uhttps://publications.gc.ca/collections/collection_2018/sc-hc/H13-9-17-2018-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/canadian-reference-product-guidance.html |
|---|
| 986 | |a180163 |
|---|